Kutywayo Kudzayi, Habib Akolade A, Caruana Edward J
Department of Thoracic Surgery, Glenfield Hospital, University Hospitals Leicester, Leicester, UK.
Interdiscip Cardiovasc Thorac Surg. 2023 Nov 2;37(5). doi: 10.1093/icvts/ivad107.
A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was: in patients who have had {visceral and parietal pleural symphysis}, {do NSAIDs reduce} {the efficacy of pleurodesis}? Sixteen papers were discovered in the search. Of these, 3 human studies were included in the analysis. None showed a significantly higher rate of pleurodesis failure in patients given perioperative NSAIDs. The results from the largest study met criteria for noninferiority. Within the constraints of the study, the results suggest that systemic administration of nonsteroidal anti-inflammatory medication in the perioperative period does not necessarily attenuate effective pleurodesis. However, further study is needed as there is a clear paucity of human-based studies.
一篇胸外科最佳证据主题文章是根据结构化方案撰写的。所探讨的问题是:在已行[脏层和壁层胸膜固定术]的患者中,[非甾体抗炎药是否会降低] [胸膜固定术的疗效]?检索发现16篇文献。其中,3项人体研究纳入分析。无一研究显示围手术期使用非甾体抗炎药的患者胸膜固定术失败率显著更高。最大规模研究的结果符合非劣效性标准。在本研究的限制范围内,结果提示围手术期全身使用非甾体抗炎药不一定会减弱有效的胸膜固定术。然而,由于基于人体的研究明显不足,仍需进一步研究。